# AVAI (Avai Bio, Inc.) - SEC EDGAR Financial Statements

> Avai Bio, Inc. reported $1.12M in total assets and a net loss of $1.61M through March 31, 2026 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/AVAI
- Markdown: https://convexityos.com/fundamentals/AVAI.md
- SEC CIK: 0001740797
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:05 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001740797&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | -- | Mar 31, 2026 |
| Operating Income | FY 2026 | -$1.61M | Operating profit |
| Net Income | FY 2026 | -$1.61M | GAAP bottom line |
| Diluted EPS | FY 2026 | -- | Split-adjusted |
| Free Cash Flow | FY 2026 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $122K | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | $276K | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | $276K | $711K | $1.23M | $461K | $0 |
| **Gross Profit** | -- | -- | -- | -$40K | $211K | -$17K | $256K | $0 |
| Research & Development | $15K | -- | -- | -- | -- | -- | $27K | $0 |
| Total Operating Expenses | $1.48M | $1.53M | $2.12M | $323K | $554K | $287K | $326K | $78K |
| **Operating Income** | -$1.75M | -$1.14M | -$2.13M | -$349K | $127K | $302K | -$70K | -$78K |
| **EBITDA** | -$1.72M | -$1.07M | -$2.05M | -$326K | -- | -- | -$30K | -$73K |
| Income Before Tax | -- | -- | -- | -- | -- | -- | -- | -$78K |
| **Net Income** | -$1.75M | -$1.14M | -$2.13M | -$349K | -$127K | -$248K | -$70K | -$78K |
| Basic EPS | -$0.01 | -$0.01 | -$0.02 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| **Diluted EPS** | -- | -- | -- | -- | -- | -- | $0.00 | $0.00 |
| Basic Shares Outstanding | 138.0M | 128.1M | 86.5M | 38.5M | 26.3M | 26.3M | 1.0M | -- |
| Diluted Shares Outstanding | -- | -- | -- | -- | -- | 26.3M | 1.0M | 4.6M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | -- | -- | -- | -- | $24K | -- | -- | -- |
| Total Operating Expenses | $253K | $420K | $88K | $510K | $395K | $488K | -$38K | $429K |
| **Operating Income** | -$253K | -$552K | -$255K | -$554K | -$453K | $488K | -$2.75M | $452K |
| **EBITDA** | -$245K | -$547K | -$249K | -$547K | -$446K | $494K | -$2.73M | $472K |
| Income Before Tax | -- | -- | -- | -- | -- | -- | -- | -$452K |
| **Net Income** | -$253K | -$552K | -$255K | -$554K | -$453K | $488K | $464K | -$452K |
| Basic EPS | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- | $0.00 |
| Basic Shares Outstanding | 154.4M | 153.9M | -- | 138.0M | 137.6M | 137.5M | -- | 137.0M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $23K | $81K | $281 | $107K | $33K | $60K | $27K | $27K | $102 | $5.7K |
| **Cash & Short-Term Investments** | $23K | $81K | $281 | $107K | $33K | $60K | $27K | $27K | $102 | $5.7K |
| Accounts Receivable, Net | $60K | -- | -- | -- | $3.8K | $64K | $30K | $1.1K | $0 | -- |
| Other Current Assets | -- | -- | -- | -- | -- | -- | -- | $0 | $55 | $8.3K |
| **Total Current Assets** | $89K | $93K | $116K | $108K | $331K | $620K | $148K | $148K | $25K | $5.7K |
| Property, Plant & Equipment, Net | $1.5K | -- | $1.5K | $1.5K | $1.5K | $1.5K | $1.5K | -- | -- | -- |
| Intangible Assets | $106K | $132K | $206K | $134K | -- | -- | -- | $218K | $3.7K | -- |
| Other Non-Current Assets | $378K | -- | -- | -- | -- | -- | -- | $2.3K | $0 | $0 |
| **Total Non-Current Assets** | $483K | $132K | $206K | $134K | $124K | $196K | $272K | $51K | $1.3K | $0 |
| **Total Assets** | $573K | $225K | $322K | $241K | $455K | $816K | $420K | $420K | $31K | $2.6K |
| Accounts Payable | $1.59M | $885K | $1.08M | $237K | $2.0K | $271K | $51K | $51K | $6.0K | $0 |
| Short-Term Debt | $25K | $30K | -- | $99K | -- | -- | -- | -- | -- | -- |
| Other Current Liabilities | $744K | $512K | $407K | $244K | -- | -- | -- | $458K | $80K | $5.0K |
| **Total Current Liabilities** | $3.39M | $1.79M | $1.79M | $875K | $860K | $1.14M | $458K | $458K | $31K | $5.0K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $458K | $80K | $0 |
| **Total Liabilities** | $3.39M | $1.79M | $1.79M | $875K | $860K | $1.14M | $458K | -$38K | $31K | $5.0K |
| **Total Debt (incl. Leases)** | $25K | $30K | -- | $99K | -- | -- | $320 | -- | -- | -- |
| Common Stock | $153K | $137K | $117K | $39K | $26K | $26K | -- | $1.1K | $0 | $0 |
| Retained Earnings | -$5.87M | -$4.12M | -$2.98M | -$848K | $496K | $369K | -$67K | -$67K | -$79K | -$739 |
| Accumulated Other Comp. Income | -- | -- | -- | -- | $169 | -$11K | -- | -- | -- | -- |
| **Total Stockholders' Equity** | -$2.82M | -$1.56M | -$1.47M | -$633K | -$406K | -$327K | -$38K | -$38K | -$50K | $3.3K |
| Total Equity | -$2.82M | -$1.56M | -$1.47M | -$633K | -$406K | -$327K | -$38K | -$38K | -$50K | $3.3K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $122K | $84K | $23K | $50K | $92K | $10K | $81K | $3.1K |
| **Cash & Short-Term Investments** | $122K | $84K | $23K | $50K | $92K | $10K | $81K | $3.1K |
| Accounts Receivable, Net | $60K | $60K | $60K | -- | -- | -- | -- | -- |
| **Total Current Assets** | $188K | $154K | $89K | $61K | $113K | $20K | $93K | $28K |
| Property, Plant & Equipment, Net | $1.5K | $1.5K | $1.5K | $1.5K | -- | -- | -- | $1.5K |
| Intangible Assets | $150K | $159K | $106K | $112K | $119K | $125K | $132K | $147K |
| Other Non-Current Assets | $781K | $479K | $378K | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $931K | $637K | $483K | $112K | $119K | $125K | $132K | $147K |
| **Total Assets** | $1.12M | $792K | $573K | $173K | $231K | $145K | $225K | $175K |
| Accounts Payable | $1.89M | $1.73M | $1.59M | $1.40M | $1.21M | $1.12M | $885K | $1.56M |
| Short-Term Debt | -- | -- | $25K | $125K | $125K | $30K | $30K | $30K |
| Other Current Liabilities | $1.36M | $803K | $744K | $698K | $700K | $632K | $512K | $541K |
| **Total Current Liabilities** | $4.53M | $4.01M | $3.39M | $2.97M | $2.53M | $2.14M | $1.79M | $2.31M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $4.53M | $4.01M | $3.39M | $2.97M | $2.53M | $2.14M | $1.79M | $2.31M |
| **Total Debt (incl. Leases)** | -- | -- | $25K | $125K | $125K | $30K | $30K | $30K |
| Common Stock | $154K | $154K | $153K | $138K | $138K | $138K | $137K | $137K |
| Retained Earnings | -$6.67M | -$6.42M | -$5.87M | -$5.61M | -$5.06M | -$4.61M | -$4.12M | -$4.58M |
| **Total Stockholders' Equity** | -$3.42M | -$3.22M | -$2.82M | -$2.79M | -$2.30M | -$1.99M | -$1.56M | -$2.14M |
| Total Equity | -$3.42M | -$3.22M | -$2.82M | -$2.79M | -$2.30M | -$1.99M | -$1.56M | $2.14M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.75M | -$1.14M | -$2.13M | -$349K | -- | -$248K | -$70K | -$78K |
| Depreciation & Amortization | $26K | $74K | $77K | $23K | -- | -- | $39K | $4.8K |
| Change in Receivables | -- | -- | -- | -- | $60K | $34K | $3.9K | $0 |
| Change in Payables | $708K | -$197K | $845K | $42K | $269K | $220K | $191K | $6.0K |
| **Operating Cash Flow** | -$1.01M | -$1.16M | -$1.32M | -$54K | $535K | -$16K | $131K | -$84K |
| Acquisitions, Net | -- | -- | -- | -- | -- | -- | -$29K | $0 |
| **Investing Cash Flow** | -- | -- | -$149K | -$34K | -$34K | $21K | -$271K | -$9.9K |
| Common Stock Issued | $16K | $20K | $26K | $12K | -- | -- | -- | -- |
| **Financing Cash Flow** | $952K | $1.24M | $1.36M | $162K | $474K | $28K | $168K | $88K |
| **Net Change in Cash** | -$58K | $81K | -$107K | $74K | -$27K | $33K | -- | -- |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$253K | -$552K | -- | -$554K | -$453K | -$488K | -$2.75M | $2.76M |
| Depreciation & Amortization | $8.6K | $5.2K | $6.5K | $6.5K | $6.5K | $6.5K | $16K | $20K |
| Change in Payables | $165K | $137K | $193K | $190K | $86K | $239K | -$680K | $312K |
| **Operating Cash Flow** | -$75K | -$414K | -$51K | -$347K | -$372K | -$240K | -$188K | -$134K |
| **Investing Cash Flow** | $0 | -$59K | -- | -- | -- | -- | -- | -- |
| Common Stock Issued | $439 | $705 | $15K | $202 | $318 | $148 | $232 | $5.3K |
| **Financing Cash Flow** | $114K | $533K | $24K | $306K | $453K | $169K | $265K | $136K |
| **Net Change in Cash** | $38K | $60K | -$27K | -$42K | $82K | -$71K | $78K | $1.3K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -14.6% | -- | -- | -- | -- |
| **Operating Margin** | -- | -- | -- | -126.3% | -- | -- | -- | -- |
| **Net Profit Margin** | -- | -- | -- | -126.3% | -- | -- | -- | -- |
| Return on Assets (ROA) | -305.5% | -508.2% | -661.0% | -144.5% | -27.8% | -30.4% | -16.6% | -256.3% |
| Current Ratio | 0.03x | 0.05x | 0.06x | 0.12x | 0.38x | 0.54x | 0.32x | 0.83x |
| Quick Ratio | 0.02x | 0.05x | 0.00x | 0.12x | 0.04x | 0.11x | 0.06x | 0.00x |
| Gross Profit Growth (YoY) | -- | -- | -- | -119.2% | -- | -106.5% | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -375.8% | -58.1% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -110.2% | -- | -112.4% | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -144.2% | -229.1% | -135.2% | -31.9% | 20.0% | -86.5% | -508.2% | -3179.0% |
| Current Ratio | 0.04x | 0.04x | 0.03x | 0.02x | 0.04x | 0.01x | 0.05x | 0.01x |
| Quick Ratio | 0.04x | 0.04x | 0.02x | 0.02x | 0.04x | 0.00x | 0.05x | 0.00x |
| Operating Income Growth (YoY) | -- | -213.2% | -- | -222.4% | -172.7% | -- | -- | -55.4% |
| **Net Income Growth (YoY)** | -- | -213.2% | -155.0% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
